Target intelligence / Profile preview

Sleeping Beauty transposon inverted terminal repeat direct repeats (SB ITR DRs)

Target
SB ITR DRs
Molecular classification
DNA element, Transposable element, Non-coding DNA sequence, Cis-regulatory element
01

Overview

The Sleeping Beauty (SB) transposon inverted terminal repeat (ITR) direct repeats (DRs) are essential DNA recognition sequences that define the boundaries of the SB transposon system. These sequences are specifically recognized and bound by the Sleeping Beauty transposase, an enzyme that facilitates the "cut-and-paste" movement of genetic material (Ivics et al., 1997). Each ITR contains two DRs—an inner and an outer repeat—which are necessary for the formation of a functional synaptic complex during the transposition process (Izsvák et al., 2000). In the context of modern biotechnology, these sequences are engineered into plasmids to deliver therapeutic genes, such as those encoding chimeric antigen receptors (CARs), into human cells (Hudecek et al., 2010). This non-viral approach offers a cost-effective alternative to viral vectors for stable gene modification in immunotherapy and gene therapy. The interaction between the transposase and the DRs ensures that only the DNA flanked by the ITRs is excised and integrated into the host genome. However, the integration process is semi-random, occurring primarily at TA dinucleotides, which poses a theoretical risk of insertional mutagenesis if the transposon disrupts critical regulatory regions (Narayanavari & Izsvák, 2017).

Other names
SB ITRsSleeping Beauty direct repeatsSB-DRsInverted terminal repeats of Sleeping BeautySB transposon ends
02

Mechanism of action

The Sleeping Beauty transposase recognizes and binds to the direct repeat (DR) sequences within the inverted terminal repeats (ITRs), facilitating the excision of the transposon from a donor plasmid and its subsequent integration into the host cell genome at TA dinucleotide sites.

03

Biological functions

DNA transpositionStable gene integrationProtein-DNA bindingSynaptic complex formation
04

Disease associations

CancerGenetic disorders
05

Safety considerations

Insertional mutagenesisGenotoxicityOff-target integrationPotential for oncogene activation
06

Interacting drugs

Sleeping Beauty transposase

2 more in the full profile.

07

Biomarkers

Vector copy number (VCN)Integration site profileTransposon excision footprintTransposase expression levels

Beyond the preview

Go deeper on Sleeping Beauty transposon inverted terminal repeat direct repeats (SB ITR DRs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sleeping Beauty transposon inverted terminal repeat direct repeats (SB ITR DRs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call